等待开盘 08-13 09:30:00 美东时间
-0.350
-1.30%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Aron Adamski downgraded Interparfums Inc (NASDAQ:IPAR) from Buy to Neutral ...
08-10 20:10
JP Morgan analyst Jeffrey Zekauskas downgrades Compass Minerals Intl (NYSE:CMP) from Neutral to Underweight and lowers the price target from $30 to $27.
08-10 18:06
Compass Minerals (NYSE:CMP) today announced the departure of Patrick Merrin, effective Aug. 3, 2026, and the promotion of Brandon Risner to chief operating officer. Edward C. Dowling Jr., president and CEO, said, "On behalf of the board of directors, I would like to thank Pat for his service and wis...
08-06 05:23
Compass Minerals Intl (NYSE:CMP) raises FY2026 sales outlook from $1.215 billion-$1.290 billion to $1.253 billion-$1.299 billion vs $1.280 billion estimate.
08-06 05:19
https://www.reuters.com/business/autos-transportation/compass-minerals-eyes-return-lithium-market-with-energyx-partnership-2026-05-18/
05-18 19:50
今日重点评级关注:HC Wainwright & Co.:维持Autolus Therapeutics"买入"评级,目标价从9美元升至10美元;Maxim Group:维持Rezolute"买入"评级,目标价从4美元升至10美元
05-15 10:49
JP Morgan analyst Jeffrey Zekauskas upgrades Compass Minerals Intl (NYSE:CMP) from Underweight to Neutral and raises the price target from $20 to $30.
05-14 21:22
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Compass Minerals Intl (NYSE:CMP) raises FY2026 sales outlook from $1.150 billion-$1.235 billion to $1.215 billion-$1.290 billion vs $1.228 billion estimate.
05-07 05:01